Medtronic (MDT) Might Post “Better Than Expected Numbers,” Says Jim Cramer

Key Highlights

• Its shares are up by 12.9% over the past year.
• The past couple of months have seen several analysts discuss the firm.
• For instance, in December, Truist kept a Hold rating on Medtronic plc (NYSE:MDT)’s shares and reduced the price target to $107 from $110, as per The Fly.
• The financial firm pointed out that the company’s near-term valuation could experience macroeconomic headwinds.
• Truist’s action came after Stifel had also kept a Hold rating on Medtronic plc (NYSE:MDT)’s stock, along with a $105 share price target.